From: Acceptance checklist for clinical effectiveness pilot trials: a systematic approach
Component of trial | Monitoring methods (exemplars) | Amend? | Outcomes (exemplars) | |
---|---|---|---|---|
Trial design | Review research protocol especially balance of scientific & practical needs | Yes/No | Amend trial design & dependent components. Submit amendment to Research Ethics Committee | |
Sample size | Test assumptions within protocol on: number of (active) centres; recruitment rates; retention rates; & SD of primary outcomes | Yes/No | Revise if necessary: sample size calculation; trial period; & funding | |
Interventions | Clinical governance | Assess compliance with: formal training in intervention; Health & Safety regulations; & other clinical governance requirements | Yes/No | Enhance formal training of intervention providers |
Intervention fidelity | Measure & assess adherence to intervention manual by video, observation or audio | Yes/No | Enhance clinical supervision of intervention providers | |
Participants | Recruitment strategy | Assess: flows of participants; cost & productivity of each route | Yes/No | Refine recruitment strategy, generally & locally |
Eligibility criteria | Assess: characteristics of sample; barriers to recruitment; update of intervention | Yes/No | Refine eligibility criteria | |
Consent procedures | Participant Information Sheets (PIS) | Consult participants & refusers | Yes/No | Refine PIS especially to address frequently asked questions |
Taking informed consent | Audit consent documentation. Measure & assess adherence to consent procedures by video, observation or audio | Yes/No | Enhance training of research team | |
Randomisation process | Check quality especially: accessibility by researchers; validity of CONSORT flowchart; & accuracy of stratifying variables | Yes/No | Refine: randomisation procedure & parameters; & training of research team | |
Blinding | Check whether assessors can predict individual allocations. Test whether unblinded researchers can keep other researchers blind | Yes/No | Refine blinding procedures, e.g. by reallocating responsibilities within research team | |
Data | Data collection | Assess adherence to interview schedules & fieldwork handbook, including duration of assessments, by video, observation or audio | Yes/No | Refine schedules to reduce assessment burden. Enhance training of research team |
Data quality | Test missing data procedures within draft analysis plan | Yes/No | Refine data collection tools & missing data procedures | |
Data management | Test trial database, related procedures & link to analytical software | Yes/No | Refine trial database & procedures | |
Research Governance | Research protocol adherence | Enable quality assurance officer (QAO) to test adherence as widely as possible | Yes/No | Refine: protocol; quality assurance plan & training of team |
Adverse events (AE) | QAO to test procedures for: reporting AEs; assessing severity, causality & expectedness monitor at management group; report to DMEC | Yes/No | Refine AE reporting & assessment procedures | |
Health & Safety | Test H&S procedures, e.g. for lone working | Yes/No | Refine H&S procedures | |
Data analysis | Test draft analysis plan on pilot data | Yes/No | Refine analysis plan to address research aims in full | |
Trial management | Review role descriptions of research team. Review remits of trial management group, trial research team etc. | Yes/No | Review role descriptions of research team. Refine roles e.g. if workloads vary. Refine remits e.g. if inadequate reporting of any component |